Answers are grounded in this paper and cite their sources.
Nanostructured lipid carriers improved skin permeation of AKBA by 1.34-fold, suggesting quality by design approaches for better risk management.
AKBA-loaded nanostructured lipid carriers significantly enhanced skin permeation (1.34-fold vs. plain gel), sustained release up to 56 h, offering a stable, promising, scalable strategy for treating inflammatory skin disorders.
No takes yet. Share an insight, caveat, or question.
Priya et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: